Eisai Co., Ltd. (ESALF) Financials
ESALF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.5 billion | 3.8 billion |
| March 31, 2026 | 9.1 billion | 3.3 billion |
| Dec. 31, 2025 | 9.5 billion | 3.6 billion |
| Sept. 30, 2025 | 9.9 billion | 3.8 billion |
ESALF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -41.8 million | ? |
| March 31, 2026 | -6.0 million | ? |
| Dec. 31, 2025 | 202.1 million | ? |
| Sept. 30, 2025 | 128.3 million | ? |
ESALF Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 111.3 million |
| March 31, 2026 | -20.5 million |
| Dec. 31, 2025 | 109.7 million |
| Sept. 30, 2025 | 69.6 million |
ESALF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.9 billion | 1.1 billion | - |
| March 31, 2026 | 1.5 billion | 849.1 million | - |
| Dec. 31, 2025 | 2.0 billion | 861.0 million | - |
| Sept. 30, 2025 | 2.1 billion | 923.5 million | - |
ESALF Shares Outstanding
ESALF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 26.0 million | 266.8 million | 700.9 million | - |
| March 31, 2026 | 31.8 million | 276.8 million | 753.1 million | - |
| Dec. 31, 2025 | 21.2 million | 250.4 million | 713.8 million | - |
| Sept. 30, 2025 | 16.9 million | 251.8 million | 711.8 million | - |
ESALF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.4 billion | 311.8 million |
| March 31, 2026 | 1.3 billion | 327.7 million |
| Dec. 31, 2025 | 1.4 billion | 326.4 million |
| Sept. 30, 2025 | 1.4 billion | 312.0 million |
ESALF
Price: $30.61
Dividend Yield: 3.37%
Forward Dividend Yield: 3.34%
Payout Ratio: 132.31%
Dividend Per Share: 1.02 USD
Earnings Per Share: 0.87 USD
P/E Ratio: 33
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Market Capitalization: 8.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 40
DGR3: 8.90%
DGR5: 3.87%
DGR10: 3.25%
DGR20: 7.31%